What to Expect During the Transition When transitioning GLP-1 medications, you can expect to experience some side effects, and a possible slowdown in your weight loss as your body adjusts to the new medication
In clinical studies, GLP-1 medications offer a protective element that supports endothelial function
Section 503A of the Federal Food, Drug, and Cosmetic Act
Specific Goals (e.g., skin brightening, detoxification): May increase to 1200 mg, 2-3 times weekly
For example, if you are prone to vitamin D deficiency, increasing your vitamin D intake might be more beneficial than it would be for someone with adequate levels
In this cohort study, most patients with overweight or obesity discontinued GLP-1 RA therapy within 1 year, but those without type 2 diabetes had higher discontinuation rates and lower reinitiation rates, the researchers concluded